OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11304	Companies
251219	Keywords
180278	Articles
137076	Press releases

Home
Companies
OXURION

BRIEF

published on 07/15/2025 at 18:05, 1 year 3 months ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE

published on 07/15/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation

Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/15/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek

Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
BRIEF

published on 07/14/2025 at 18:05, 1 year 3 months ago

Oxurion Announces Transparency Notifications from Atlas

Biopharmaceutical Shareholder Notification Atlas Special Opportunities Oxurion NV Transparency Legislation
BRIEF

published on 07/14/2025 at 18:05, 1 year 3 months ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence
PRESS RELEASE

published on 07/14/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation

Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/14/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV heeft transparantiekennisgevingen ontvangen volgens de Belgische wetgeving betreffende belangrijke deelnemingen. Atlas Special Opportunities II LLC heeft aanzienlijke aandelen in Oxurion verworven en verkocht. Raadpleeg www.oxurion.com voor meer informatie

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Belgische Wetgeving Atlas Special Opportunities II LLC
BRIEF

published on 07/10/2025 at 17:50, 1 year 3 months ago

Oxurion Clears Regulatory Hurdle in Axiodis Acquisition

Acquisition Regulatory Approval Oxurion Axiodis FDI Procedure
BRIEF

published on 07/10/2025 at 17:50, 1 year 3 months ago

Oxurion franchit l'obstacle réglementaire lors de l'acquisition d'Axiodis

Acquisition Approbation Réglementaire Oxurion Axiodis Procédure D'IDE
PRESS RELEASE

published on 07/10/2025 at 17:45, 1 year 3 months ago

Oxurion kondigt het vervullen van de tweede opschortende voorwaarde aan in de overname van Axiodis
Oxurion NV erfüllt zweite aufschiebende Bedingung für die Übernahme von Axiodis CRO. Regulierung der FDI-Prozedur abgeschlossen. Finanzierung und Abschluss innerhalb von 30 Tagen geplant

Übernahme Finanzierung Oxurion NV FDI-Prozedur Klinische Forschung

Accesswire

Published on 11/10/2026 at 08:00, 1 hour 25 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 6 hours 40 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 10 hours 15 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 10 hours 25 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 10 hours 53 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 09:15, 10 minutes ago

AssureTrace Appoints Graham Clark as Business Director and Chief Revenue Officer
Published on 11/10/2026 at 09:05, 20 minutes ago

Cepheid Achieves CE Marking Under IVDR for Xpert® Respiratory Panel
Published on 11/10/2026 at 09:05, 20 minutes ago

Jackery Black Friday 2026: Up to 58% Off Explorer v2 Portable Power Stations and Solar Generators, Starting at Just £378
Published on 11/10/2026 at 09:00, 25 minutes ago

Original-Research: q.beyond AG (von NuWays AG): BUY
Published on 11/10/2026 at 09:00, 25 minutes ago

Official List Notice

Les Echos

Published on 11/10/2026 at 07:00, 2 hours 25 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 2 hours 25 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 14 hours 55 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 14 hours 55 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 15 hours 40 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE